We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+6.89%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$53.9B
AUM Growth
-$1.63B
(-2.9%)
Cap. Flow
-$3.55B
Cap. Flow
% of AUM
-6.58%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,489
New
41
Increased
394
Reduced
550
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$74.8M |
| 2 |
Sysco
SYY
|
+$54M |
| 3 |
ExxonMobil
XOM
|
+$42.4M |
| 4 |
Progressive
PGR
|
+$40.9M |
| 5 |
Mondelez International
MDLZ
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.68B |
| 2 |
Broadcom
AVGO
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Canadian Natural Resources
CNQ
|
+$77.6M |
| 5 |
Gilead Sciences
GILD
|
+$60.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.08% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Annaly Capital Management
NLY
$17.6B
| $1.44M | ﹤0.01% |
71,328
-1,153
| -2% | -$23.1K |
|
827
Edgewise Therapeutics
EWTX
$4.82B
| $1.44M | ﹤0.01% |
80,000
| – | – |
|
828
Bio-Techne
TECH
$11.2B
| $1.42M | ﹤0.01% |
18,187
-643
| -3% | -$48.3K |
|
829
Charles River Laboratories
CRL
$13.5B
| $1.41M | ﹤0.01% |
7,142
-764
| -10% | -$159K |
|
830
Axos Financial
AX
$5.67B
| $1.38M | ﹤0.01% |
22,226
+431
| +2% | +$28.3K |
|
831
Tencent Music
TME
$13.8B
| $1.35M | ﹤0.01% |
101,362
-80
| -0.1% | -$979 |
|
832
Kite Realty
KRG
$5.24B
| $1.34M | ﹤0.01% |
51,927
+1,737
| +3% | +$43.1K |
|
833
Arcutis Biotherapeutics
ARQT
$3.29B
| $1.34M | ﹤0.01% |
140,000
| – | – |
|
834
Toll Brothers
TOL
$14.1B
| $1.33M | ﹤0.01% |
8,591
-200
| -2% | -$27.1K |
|
835
ANI Pharmaceuticals
ANIP
$1.7B
| $1.32M | ﹤0.01% |
23,022
| – | – |
|
836
CNO Financial Group
CNO
$5.05B
| $1.31M | ﹤0.01% |
38,711
+4,127
| +12% | +$133K |
|
|
NUVL
837
DELISTED
Nuvalent
NUVL
| $1.3M | ﹤0.01% |
17,000
| – | – |
|
838
TORM
TRMD
$2.95B
| $1.29M | ﹤0.01% |
38,000
+35,000
| +1,167% | +$1.28M |
|
839
MarketAxess Holdings
MKTX
$5.72B
| $1.29M | ﹤0.01% |
5,080
+52
| +1% | +$12.2K |
|
840
Teva Pharmaceuticals
TEVA
$43.1B
| $1.28M | ﹤0.01% |
73,580
-4,739
| -6% | -$82.9K |
|
841
Liberty Broadband Class C
LBRDK
$5.12B
| $1.26M | ﹤0.01% |
+16,251
| New | +$1M |
|
842
National Healthcare
NHC
$3.46B
| $1.25M | ﹤0.01% |
10,411
+9,655
| +1,277% | +$1.21M |
|
|
WBA
843
DELISTED
Walgreens Boots Alliance
WBA
| $1.25M | ﹤0.01% |
136,013
-11,292
| -8% | -$116K |
|
844
Alamos Gold
AGI
$14.3B
| $1.24M | ﹤0.01% |
61,800
| – | – |
|
845
Wynn Resorts
WYNN
$10.8B
| $1.23M | ﹤0.01% |
12,356
+398
| +3% | +$32K |
|
846
United Airlines
UAL
$40.9B
| $1.21M | ﹤0.01% |
20,951
+421
| +2% | +$19.5K |
|
|
DAY
847
DELISTED
Dayforce
DAY
| $1.19M | ﹤0.01% |
19,984
-547
| -3% | -$30.1K |
|
848
Ovintiv
OVV
$17.6B
| $1.19M | ﹤0.01% |
31,213
-1,600
| -5% | -$69.2K |
|
849
U-Haul Holding Co Series N
UHAL.B
$12.6B
| $1.19M | ﹤0.01% |
16,772
+999
| +6% | +$64.9K |
|
|
NSA
850
DELISTED
National Storage Affiliates Trust
NSA
| $1.19M | ﹤0.01% |
25,133
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2024 Portfolio in Review
As of Q3 2024, DekaBank Deutsche Girozentrale held 1,489 positions worth $53.9B, down 2.9% from $55.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
DekaBank Deutsche Girozentrale withdrew a net $3.55B in Q3 2024, closing 60 positions and reducing 550 holdings. Its most notable exit was Labcorp, an estimated $36.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.
Against the trend, DekaBank Deutsche Girozentrale opened a new position in SolarEdge worth $1.5M.
- DekaBank Deutsche Girozentrale's largest Q3 2024 buy was SolarEdge: 66,000 shares worth $1.5M.
- DekaBank Deutsche Girozentrale added most to CVS Health in Q3 2024, an estimated $74.8M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.68B.
- DekaBank Deutsche Girozentrale fully exited Labcorp in Q3 2024, selling an estimated $36.3M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 26% of its $53.9B portfolio in Q3 2024.
- DekaBank Deutsche Girozentrale opened 41 new positions and closed 60 in Q3 2024.
- DekaBank Deutsche Girozentrale's portfolio value fell 2.9% quarter-over-quarter to $53.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2024, filed 24 Oct 2024.